Tag

M/s. Kunal Dutt & Associates

1 article

Goldline Pharma FY26 PAT ₹411.71 Lakh, EPS ₹5.97

Goldline Pharmaceutical approved FY26 standalone results with PAT of ₹411.71 lakh and EPS of ₹5.97, a significant increase from previous year. Appointed M/s. Kunal Dutt & Associates as Internal Audito